Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
Year: 1992
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: University of Alabama at Birmingham
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W1555211613
